Affymetrix Inc (AFFX)

Affymetrix, Inc. provides life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level. It has two segments, Affymetrix Core and eBioscience. Affymetrix Core segment engages in development, manufacture, and commercialization of systems for genetic analysis in life sciences, AgBio, and diagnostic industry. It develops and markets GeneChip gene expression products and services; genotyping product line; products with clinical diagnostic and research applications, such as the CytoScan and OncoScan products; GeneTitan instrument system that runs genotyping and gene expression array plates; and QuantiGene line of singleplex and multiplex assays to serve customers in the research and translational medicine markets. It also offers life science reagents, such as ExoSAP-IT for a reagent for clean-up of polymerase chain reaction, and HotStart-IT reagents to inhibit primer dimer formation; enzymes; purification kits; and biochemicals for life science researchers and other biological and health care manufacturers. eBioscience segment develops, manufactures, markets, and distributes research products in the areas of flow cytometry, immunoassays, microscopic imaging, and other protein-based analyses. This segment offers a portfolio of antibodies and reagents, as well as a range of the QuantiGene and Procarta Plex assays for low to mid-plex experiments. The company sells its products to genomic research centers, academic institutions, and government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies, primarily through third party distributors in Mexico, India, Brazil, the Middle East, and the Asia Pacific, including China. It has a strategic partnership with Cytox Ltd. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California. As of March 31, 2016, Affymetrix Inc. operates as a subsidiary of Life Technologies Corporation